These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22954244)

  • 1. Osteoporosis is a major confounder in observational studies investigating bisphosphonate therapy in aortic stenosis.
    Dweck MR; Newby DE
    J Am Coll Cardiol; 2012 Sep; 60(11):1027; author reply 1027. PubMed ID: 22954244
    [No Abstract]   [Full Text] [Related]  

  • 2. Do bisphosphonates slow the progression of aortic stenosis?
    Aksoy O; Cam A; Goel SS; Houghtaling PL; Williams S; Ruiz-Rodriguez E; Menon V; Kapadia SR; Tuzcu EM; Blackstone EH; Griffin BP
    J Am Coll Cardiol; 2012 Apr; 59(16):1452-9. PubMed ID: 22497825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearts of Stone: Calcific Aortic Stenosis and Antiresorptive Agents for Osteoporosis.
    Demer LL; Tintut Y
    Circulation; 2021 Jun; 143(25):2428-2430. PubMed ID: 34152795
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of bisphosphonates on the progression of degenerative aortic stenosis.
    Innasimuthu AL; Katz WE
    Echocardiography; 2011 Jan; 28(1):1-7. PubMed ID: 20678125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates in calcific aortic stenosis: association with slower progression in mild disease--a pilot retrospective study.
    Sterbakova G; Vyskocil V; Linhartova K
    Cardiology; 2010; 117(3):184-9. PubMed ID: 21079402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering therapy in calcific aortic stenosis.
    Chan KL; Teo K
    N Engl J Med; 2005 Sep; 353(10):1066-7; author reply 1066-7. PubMed ID: 16148295
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone Mineral Density and Progression Rate of Calcific Aortic Valve Stenosis.
    Tastet L; Shen M; Capoulade R; Arsenault M; Bédard É; Côté N; Clavel MA; Pibarot P
    J Am Coll Cardiol; 2020 Apr; 75(14):1725-1726. PubMed ID: 32273038
    [No Abstract]   [Full Text] [Related]  

  • 8. Aortic valve stenosis and lipid-lowering therapy: the state of the art.
    Bonadei I; Vizzardi E; D'aloia A; Gelsomino S; De Cicco G; Lorusso R; Dei Cas L
    Panminerva Med; 2013 Dec; 55(4):391-5. PubMed ID: 24434347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of bisphosphonates in pediatrics.
    Baroncelli GI; Bertelloni S
    Horm Res Paediatr; 2014; 82(5):290-302. PubMed ID: 25376487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slower Progress of Aortic Valve Calcification With Vitamin K Supplementation: Results From a Prospective Interventional Proof-of-Concept Study.
    Brandenburg VM; Reinartz S; Kaesler N; Krüger T; Dirrichs T; Kramann R; Peeters F; Floege J; Keszei A; Marx N; Schurgers LJ; Koos R
    Circulation; 2017 May; 135(21):2081-2083. PubMed ID: 28533322
    [No Abstract]   [Full Text] [Related]  

  • 11. Medical therapy for calcific aortic stenosis: the use of bisphosphonates.
    Elmariah S; Rajamannan NM
    Cardiology; 2010; 117(3):229-30. PubMed ID: 21212671
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone modifiers and the quest to slow progression of aortic stenosis.
    Goldstein RE
    Am J Cardiol; 2009 Jul; 104(1):125-7. PubMed ID: 19576332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoporosis and Aortic Stenosis: 'Killing Two Birds with One Stone'?
    Lazaros G; Benetos G; Toutouzas K; Tousoulis D
    Cardiology; 2015; 132(1):9-10. PubMed ID: 25997816
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of calcinosis using pamidronate in a patient with juvenile dermatomyositis.
    Martillotti J; Moote D; Zemel L
    Pediatr Radiol; 2014 Jan; 44(1):115-8. PubMed ID: 23839717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SALTIRE-RAAVE: targeting calcific aortic valve disease LDL-density-radius theory.
    Rajamannan NM; Greve AM; Moura LM; Best P; Wachtell K
    Expert Rev Cardiovasc Ther; 2015 Apr; 13(4):355-67. PubMed ID: 25797901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate.
    Slimani S; Abdessemed A; Haddouche A; Ladjouze-Rezig A
    Joint Bone Spine; 2010 Jan; 77(1):70-2. PubMed ID: 20031471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating aortic stenosis: arresting the snowball effect.
    Pawade TA; Newby DE
    Expert Rev Cardiovasc Ther; 2015 May; 13(5):461-3. PubMed ID: 25882205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapy to prevent progression of calcific aortic stenosis.
    Rajamannan NM; Otto CM
    Circulation; 2004 Sep; 110(10):1180-2. PubMed ID: 15353511
    [No Abstract]   [Full Text] [Related]  

  • 19. What is a 'failure' of bisphosphonate therapy for osteoporosis?
    Carey JJ
    Cleve Clin J Med; 2005 Nov; 72(11):1033-9. PubMed ID: 16315442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial commentary: Lp(a) and calcific aortic valve stenosis: Direct LPA targeting or PCSK9-Lowering therapy?
    Capoulade R; Cariou B
    Trends Cardiovasc Med; 2021 Jul; 31(5):312-314. PubMed ID: 32623063
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.